Lapatinib or trastuzumab? Which anti-HER2 treatment is more effective in the treatment of patients with HER2-positive breast cancer with brain metastases? An Anatolian Society of Medical Oncology Study

Basit Öğe Kaydı
dc.authoridkoçer, murat/0000-0002-1541-640X
dc.authoridElkıran, Emin Tamer/0000-0001-6681-7249
dc.authoridOzturk, Banu/0000-0003-0290-8787
dc.authoridKOÇER, Murat/0000-0002-1541-640X
dc.authoridGumusay, Ozge/0000-0002-6236-9829;
dc.authorwosidDurnalı, Ayşe/AAZ-8847-2021
dc.authorwosidkoçer, murat/AAD-2345-2019
dc.authorwosidKucukoner, Mehmet/E-1162-2013
dc.authorwosidElkıran, Emin Tamer/ABI-8192-2020
dc.authorwosidGeredeli, Caglayan/AAN-4122-2020
dc.authorwosidOzturk, Banu/AAD-4358-2019
dc.authorwosidKOÇER, Murat/GQH-4487-2022
dc.contributor.authorKaplan, Muhammet Ali
dc.contributor.authorIsikdogan, Abdurrahman
dc.contributor.authorKoca, Dogan
dc.contributor.authorKucukoner, Mehmet
dc.contributor.authorGumusay, Ozge
dc.contributor.authorYildiz, Ramazan
dc.contributor.authorOztop, Ilhan
dc.date.accessioned2024-08-04T20:59:49Z
dc.date.available2024-08-04T20:59:49Z
dc.date.issued2012
dc.departmentİnönü Üniversitesien_US
dc.description48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- JUN 01-06, 2012 -- Chicago, ILen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue15en_US
dc.identifier.urihttps://hdl.handle.net/11616/103567
dc.identifier.volume30en_US
dc.identifier.wosWOS:000318009800398en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAmer Soc Clinical Oncologyen_US
dc.relation.ispartofJournal of Clinical Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleLapatinib or trastuzumab? Which anti-HER2 treatment is more effective in the treatment of patients with HER2-positive breast cancer with brain metastases? An Anatolian Society of Medical Oncology Studyen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu